Home  |  Contact

Cellosaurus MDA-MB-468 shWDR12-4 (CVCL_YJ27)

[Text version]

Cell line name MDA-MB-468 shWDR12-4
Accession CVCL_YJ27
Resource Identification Initiative To cite this cell line use: MDA-MB-468 shWDR12-4 (RRID:CVCL_YJ27)
Comments Group: Triple negative breast cancer (TNBC) cell line.
Doubling time: 24-31 hours (CelloPub=CLPUB00550).
Knockout cell: Method=shRNA knockdown; HGNC; 14098; WDR12.
Miscellaneous: Corrections of STR profile from thesis manuscript (CelloPub=CLPUB00550) from personal communication of Al-Awar R.
Sequence variations Homozygous for PTEN c.253+1G>T; splice donor mutation (from parent cell line).
Homozygous for RB1 c.265_2787del2523 (from parent cell line).
Homozygous for TP53 p.Arg273His (c.818G>A) (ClinVar=VCV000012366) (from parent cell line).
Disease Breast adenocarcinoma (NCIt: C5214)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0419 (MDA-MB-468)
Sex of cell Female
Age at sampling 51Y
Category Cancer cell line
STR profile Source(s): CelloPub=CLPUB00550; Direct_author_submission

Markers:
AmelogeninX
CSF1PO12,13
D5S81812
D7S8208
D13S31712
D16S5399
D21S1127,28
TH017
TPOX8,9
vWA18

Run an STR similarity search on this cell line
Publications

CLPUB00550
Benhamron S.
Validating WDR12 as a potential drug target in triple negative breast cancer.
Thesis MSc (2019), University of Toronto, Canada

Cross-references
Other Wikidata; Q95987445
Entry history
Entry creation19-Dec-2019
Last entry updated02-Jul-2020
Version number3